Staff Report
ISLAMABAD: Pakistan Single Window (PSW) in collaboration with the Drug Regulatory Authority of Pakistan (DRAP) has successfully integrated all existing entities, licenses and product registration of drugs with the PSW platform and has begun the gradual roll-out of various services.
The initiative was aimed to enhance transparency, efficiency and ease of doing business for pharmaceutical companies, commercial importers, healthcare institutions and humanitarian organizations involved in imports of finished drugs.
In the current phase, PSW will offer digital services related to the electronic submission and issuance of Drug Import Licenses of all types, along with the release order for donated unregistered drugs imported by hospitals, NGOs and other organizations.
The services shall be available on the PSW platform from the beginning of January 2024 and are envisaged to reduce the time and cost of pharmaceutical imports to ensure faster delivery to the sick and needy.
In this regard, a webinar was organized by PSW for Drug Import License holders, Drug Manufacturing License holders, Custom Agents and members of various trade and pharmaceutical associations and chambers to give them a walkthrough of the new processes and facilitate a seamless transition to the digital environment.
